Skip to content

Precise Percutaneous Coronary Intervention Plan (P3) Study

Prospective Evaluation of a Virtual Non-invasive Percutaneous Intervention Planner in Patients With Coronary Artery Disease.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03782688
Acronym
P3
Enrollment
127
Registered
2018-12-20
Start date
2019-02-01
Completion date
2021-12-18
Last updated
2023-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Coronary Artery Disease

Brief summary

The PRECISE PERCUTANEOUS CORONARY INTERVENTION (PCI) PLAN STUDY is an investigator-initiated, international and multicenter study of patients with an indication for PCI aiming at assessing the agreement and accuracy of the HeartFlow Planner with invasive fractional flow reserve (FFR) as a reference.

Detailed description

Multicenter study, including 120 patients at 5 centers in Europe and Asia. After identifying the presence of significant coronary stenosis by means of coronary angiography and invasive fractional flow reserve (FFR≤0.80) the patients will undergo the following procedures: Invasive FFR with intravenous adenosine (i.e. pre- and post-PCI). Optical coherence tomography-guided PCI (i.e. pre- and post-procedural imaging). PCI with newer generation drug-eluting stent.

Interventions

DIAGNOSTIC_TESTFFRCT planner

Non-invasive post-PCI fractional flow reserve prediction

Sponsors

Onze Lieve Vrouw Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Coronary artery disease in a major epicardial vessel with an invasive fractional flow reserve (FFR) ≤0.80 * An indication to Percutaneous coronary intervention

Exclusion criteria

\- Angiographic

Design outcomes

Primary

MeasureTime frameDescription
Agreement on post-PCI fractional flow reserve between virtual treatment based on FFRct planner and measured invasive post-PCI fractional flow reserve.The primary endpoint will be assessed immediately after the procedure (PCI).The agreement will be assessed by Bland Altman method

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026